Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Investigational Cancer Drug
Sort By
Newest First
Sign in
1 / 1
1 / 1
Oncology
Changing the Paradigm of Cancer Drug Discovery and Development with Plants
Martin Brenner, DVM, Ph.D.; Randy Maddux; Steven King
iBio, Inc.
PAO-02-022-CL-02
Mar 12, 2022
Orphan Drug
Trovagene Receives Positive Opinion for Orphan Drug Designation in the European Union for PCM-075, Trovagene's Investigational Cancer Drug
Trovagene
PR-M08-18-NI-032
Aug 09, 2018
